Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients

Tyrosine kinase inhibitors (TKIs), VEGF/VEGF receptor inhibitors (VEGFIs) and immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers including non-small-cell lung cancer (NSCLC). This study aims to evaluate the utility of plasma cell-free DNA (cfDNA) as a prognosti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Zhou, Xiaorong, Li, Chenchen, Zhang, Zhao, Li, Daniel Y., Du, Jinwei, Ding, Ping, Meng, Haiyan, Xu, Hui, Li, Ronglei, Ho, Effie, Zhang, Aiguo, Okunieff, Paul, Lu, Jianwei, Sha, Michael Y.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8027214/
https://ncbi.nlm.nih.gov/pubmed/33828112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-85797-z
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki